John Crowley
Impact in
- Hematology top 0.01%
- Multiple Myeloma Research and Treatments
- Oncology top 0.05%
- Peptidase Inhibition and Analysis
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
Papers in
- Hematology 168
- Multiple Myeloma Research and Treatments 165
- Oncology 128
- Cancer Treatment and Pharmacology 58
- Lung Cancer Research Studies 30
- Co-authors
- Bart Barlogie (133 shared papers)Kari Chansky (27 shared papers)Ramón Rami–Porta (9 shared papers)Dorothy J. Giroux (14 shared papers)Peter Goldstraw (10 shared papers)Elias Anaissie (48 shared papers)Valerie W. Rusch (8 shared papers)Frits van Rhee (68 shared papers)
- Journals
- Blood (86 papers)Journal of Clinical Oncology (63 papers)Journal of Thoracic Oncology (20 papers)British Journal of Haematology (12 papers)Clinical Cancer Research (12 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
John Crowley
349 papers receiving 28.7k citations
John Crowley's Hit Papers
Peers
Comparison fields: 5 of 183
- Hematology 11.1k
- Oncology 10.1k
- Pulmonary and Respiratory Medicine 8.1k
- Genetics 1.7k
- Cancer Research 2.0k
Countries citing papers authored by John Crowley
This map shows the geographic impact of John Crowley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Crowley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Crowley more than expected).
Fields of papers citing papers by John Crowley
This network shows the impact of papers produced by John Crowley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Crowley. The network helps show where John Crowley may publish in the future.
Co-authors
The 25 scholars most cited alongside John Crowley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 360 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours Hit paper breakdown → | 2007 | 2997 |
| 2 | Antitumor Activity of Thalidomide in Refractory Multiple Myeloma Hit paper breakdown → | 1999 | 2052 |
| 3 | Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial Hit paper breakdown → | 2001 | 953 |
| 4 | The molecular classification of multiple myeloma Hit paper breakdown → | 2006 | 811 |
| 5 | National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000 Hit paper breakdown → | 2001 | 748 |
| 6 | Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma Hit paper breakdown → | 2006 | 556 |
| 7 | The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer Hit paper breakdown → | 2015 | 548 |
| 8 | Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells Hit paper breakdown → | 2002 | 523 |
| 9 | Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women Hit paper breakdown → | 1988 | 513 |
| 10 | Increased Epidermal Growth Factor Receptor Gene Copy Number Detected by Fluorescence In Situ Hybridization Associates With Increased Sensitivity to Gefitinib in Patients With Bronchioloalveolar Carcinoma Subtypes: A Southwest Oncology Group Study Hit paper breakdown → | 2005 | 509 |
| 11 | The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer Hit paper breakdown → | 2007 | 498 |
| 12 | The International Association for the Study of Lung Cancer Lung Cancer Staging Project Hit paper breakdown → | 2015 | 475 |
| 13 | 1997 | 432 | |
| 14 | 2009 | 411 | |
| 15 | 2007 | 394 | |
| 16 | 2007 | 381 | |
| 17 | 2003 | 376 | |
| 18 | 2009 | 375 | |
| 19 | 1995 | 373 | |
| 20 | 1993 | 372 |
About John Crowley
John Crowley is a scholar working on Hematology, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Statistics and Probability, having authored 360 papers that have together received 29.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (165 papers), Protein Degradation and Inhibitors (61 papers), Cancer Treatment and Pharmacology (58 papers), Lung Cancer Treatments and Mutations (40 papers), Cancer therapeutics and mechanisms (36 papers), Statistical Methods in Clinical Trials (33 papers), Lung Cancer Diagnosis and Treatment (30 papers) and Lung Cancer Research Studies (30 papers). The work is most often cited by research in Hematology (11.1k citations), Oncology (10.1k citations), Pulmonary and Respiratory Medicine (8.1k citations), Genetics (1.7k citations) and Cancer Research (2.0k citations). John Crowley has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Bart Barlogie, Kari Chansky, Ramón Rami–Porta, Dorothy J. Giroux, Peter Goldstraw, Elias Anaissie, Valerie W. Rusch, Frits van Rhee, Guido Tricot and John D. Shaughnessy. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of Thoracic Oncology, British Journal of Haematology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.